NCT02358070
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Stanford Liver Transplant Clinic Stanford, California, United States
Clinical trial condition
Hepatocellular Carcinoma
Explore clinical trials studying Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
1,013 public trials
264 recruiting studies
Hepatocellular Carcinoma trial results
Completed
Dual and Single Switching Monopolar RFA Using Separable Clustered Electrode for Treatment of HCC
NCT03699657
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Seoul National University Hospital Seoul, South Korea
NCT01347333
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- St. John's Mercy Medical Center St Louis, Missouri, United States
NCT01833299
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Cancer Centre of Sun Yat-Sen University Guangzhou, China
Completed
IMA970A Plus CV8102 in Very Early, Early and Intermediate Stage Hepatocellular Carcinoma Patients
NCT03203005
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Universitair Ziekenhuis Antwerpen (UZA), Division of Gastroenterology and Hepatology Edegem, Belgium
- Universitätsklinik für Allgemeine, Viszeral- und Transplantationschirurgie Tübingen, Germany
- Istituto Nazionale Tumori "Pascale" (INTNA) Naples, Italy
- Ospedale Sacro Cuore-Don Calabria U.O.C. Oncologica Medica Negrar, Italy
NCT02240433
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Kanagawa, Japan
- For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Suita-shi, Japan
NCT03804593
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +16 more
- Locations
-
- USC Keck Medical Center Los Angeles, California, United States
- California Liver Research Institute Pasadena, California, United States
NCT03053596
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Cliniques Universitaires Saint Luc Brussels, Belgium
- Hôpital Erasme Brussels, Belgium
- Hôpital Beaujon Clinchamp, France
- CHRU Lille Lille, France
NCT02548780
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +10 more
- Locations
-
- Evgenidio Therapeftirio "Agia Trias" Athens, Greece
- Hospital Clínic i provincial de Barcelona Barcelona, Spain
- Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland
NCT00825877
- Conditions
- Adenocarcinoma, Ascites, Blood-Borne Infections, +23 more
- Locations
-
- National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States